1. Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.

    Cancer Research 76(8):2177 (2016) PMID 26862115 PMCID PMC4873424

    VHL-deficient clear cell renal cell carcinomas (ccRCC), the most common form of kidney cancer, express transcripts derived from the novel human endogenous retrovirus HERV-E (named CT-RCC HERV-E). In this study, we define a transcript encoding the entire envelope gene of HERV-E as expressed selec...
  2. Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

    PLoS ONE 10(5):e0123369 (2015) PMID 25961819 PMCID PMC4427300

    The SEMA3B gene is located in the 3p21.3 LUCA region, which is frequently affected in different types of cancer. The objective of our study was to expand our knowledge of the SEMA3B gene as a tumor suppressor and the mechanisms of its inactivation. In this study, several experimental approaches ...
  3. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

    Epigenetics 8(4):409 (2013) PMID 23478628 PMCID PMC3674050

    Genetic and epigenetic alterations in cervical carcinomas were investigated using NotI-microarrays containing 180 cloned sequences flanking all NotI-sites associated with genes on chromosome 3. In total, 48 paired normal/tumor DNA samples, specifically enriched in NotI-sites, were hybridized to ...
  4. LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.

    Biochimie 94(5):1151 (2012) PMID 22321817

    Chromosome 3 specific NotI microarrays containing 180 NotI linking clones associated with 188 genes were hybridized to NotI representation probes prepared using matched tumor/normal samples from major epithelial cancers: breast (47 pairs), lung (40 pairs) cervical (43 pairs), kidney (34 pairs of...
  5. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

    Epigenetics 7(5):502 (2012) PMID 22491060

    This study aimed to clarify genetic and epigenetic alterations that occur during lung carcinogenesis and to design perspective sets of newly identified biomarkers. The original method includes chromosome 3 specific NotI-microarrays containing 180 NotI clones associated with genes for hybridizati...
  6. Differential expression of CHL1 gene during development of major human cancers.

    PLoS ONE 6(3):e15612 (2011) PMID 21408220 PMCID PMC3049765

    CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis. We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to...
  7. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

    BMC Cancer 10:75 (2010) PMID 20193080 PMCID PMC2841140

    The short arm of human chromosome 3 is involved in the development of many cancers including lung cancer. Three bona fide lung cancer tumor suppressor genes namely RBSP3 (AP20 region),NPRL2 and RASSF1A (LUCA region) were identified in the 3p21.3 region. We have shown previously that homozygous d...
  8. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

    PLoS ONE 4(5):e5231 (2009) PMID 19478941 PMCID PMC2684631

    Many different genetic alterations are observed in cancer cells. Individual cancer genes display point mutations such as base changes, insertions and deletions that initiate and promote cancer growth and spread. Somatic hypermutation is a powerful mechanism for generation of different mutations....
  9. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development.

    BMC Developmental Biology 9:22 (2009) PMID 19291313 PMCID PMC2666674

    Transmembrane CAIX and CAXII are members of the alpha carbonic anhydrase (CA) family. They play a crucial role in differentiation, proliferation, and pH regulation. Expression of CAIX and CAXII proteins in tumor tissues is primarily induced by hypoxia and this is particularly true for CAIX, whic...
  10. Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

    Biochemical and Biophysical Research Communicat... 370(4):536 (2008) PMID 18359287 PMCID PMC2413015

    Mutations in the VHL gene are associated with highly vascular tumors of kidney, brain, retina, and adrenal gland. The inability of the mutant VHL protein to destabilize HIF-1 plays a crucial role in malignant angiogenesis. VHL is also associated with ECM assembly but the molecular mechanisms of ...
  11. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

    Journal of Clinical Investigation 118(3):1099 (2008) PMID 18292810 PMCID PMC2248804

    Transplanted donor lymphocytes infused during hematopoietic stem cell transplantation (HSCT) have been shown to cure patients with hematological malignancies. However, less is known about the effects of HSCT on metastatic solid tumors. Thus, a better understanding of the immune cells and their t...
  12. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

    PLoS ONE 3(8):e3031 (2008) PMID 18725949 PMCID PMC2516603

    We identified two 3p21.3 regions (LUCA and AP20) as most frequently affected in lung, breast and other carcinomas and reported their fine physical and gene maps. It is becoming increasingly clear that each of these two regions contains several TSGs. Until now TSGs which were isolated from AP20 a...
  13. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

    Cancer Letters 257(2):199 (2007) PMID 17720308

    Reduced expression or loss of tumor suppressor genes play a key role in many cancers. In this study, we investigated the role of RASSF1A in the pathogenesis of esophageal squamous cell carcinoma (ESCC) and nasopharyngeal carcinoma (NPC). We detected the down-regulated expression of both RASSF1A ...
  14. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.

    International Journal of Cancer 119(12):2821 (2006) PMID 16929489

    Chromosome 3p plays an important role in tumorigenesis in many cancers, including nasopharyngeal carcinoma (NPC). We have previously shown chromosome 3p can suppress tumor growth in vivo by using the monochromosome transfer approach, which indicated the chromosome 3p21.3 region was critical for ...
  15. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.

    Genes, Chromosomes and Cancer 45(7):676 (2006) PMID 16607615

    Homozygous deletions or loss of heterozygosity (LOH) at human chromosome band 3p12 are consistent features of lung and other malignancies, suggesting the presence of a tumor suppressor gene(s) (TSG) at this location. Only one gene has been cloned thus far from the overlapping region deleted in l...
  16. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.

    Cancer Letters 234(2):184 (2006) PMID 15885884

    The expression of six chromosome 3p21.3 candidate tumor suppressor genes (BLU, FUS2, HYAL2, NPRL2, RASSF1A, and SEMA3B) in esophageal squamous cell carcinoma (ESCC) has been investigated. Reduced expression of BLU was detected in some ESCC cell lines and tumor tissues and the difference was quan...
  17. Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter.

    Journal of Molecular Biology 346(2):411 (2005) PMID 15670593

    Immune responses to invading pathogens are mediated largely through a family of transmembrane Toll-like receptors and modulated by a number of downstream effectors. In particular, a family of four interleukin 1 receptor-associated kinases (IRAK) regulates responsiveness to bacterial endotoxins. ...
  18. Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus.

    Retrovirology 2:59 (2005) PMID 16191204 PMCID PMC1262777

    Infection by jaagsiekte sheep retrovirus (JSRV) and by enzootic nasal tumor virus (ENTV) depends on cell-surface expression of the virus entry receptor, hyaluronidase 2 (Hyal2). Human Hyal2 binds the envelope (Env) proteins of these viruses and is functional as a receptor, but Hyal2 from mice do...
  19. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

    Cancer Research 64(18):6438 (2004) PMID 15374952

    Initial analysis identified the NPRL2/G21 gene located in 3p21.3C, the lung cancer region, as a strong candidate tumor suppressor gene. Here we provide additional evidence of the tumor suppressor function of NPRL2/G21. The gene has highly conserved homologs/orthologs ranging from yeast to humans...
  20. Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

    The American Journal of Pathology 165(3):1007 (2004) PMID 15331424 PMCID PMC1618598

    CACNA2D2 is a putative tumor suppressor gene located in the human chromosome 3p21.3 region that shows frequent allelic imbalances in lung, breast, and other cancers. The alpha2delta-2 protein encoded by the gene is a regulatory subunit of voltage-dependent calcium channels and is expressed in br...